Indigo

Indigo is a healthcare startup committed to lighting up the lives of millions of people living with chronic disease. Founded in 2016 and headquartered in Belgium, the company is pioneering the development of medical devices using proprietary nanophotonics technology. Their flagship product is the Continuous Multi-Metabolite Monitoring (CMM®) sensor, which is the world's first subcutaneously implanted sensor for continuous and accurate glucose, ketone, and lactate monitoring, without the need for an external device. The latest milestone for Indigo is the €38.00M Series B investment led by investors such as Ackermans & van Haaren, Imec.xpand, PMV, QBIC, Thuja Capital, Fidimec, Titan Baratto, SoFi, Manuardeo, Parana Management on 27 July 2020. With a focus on Health Care and Medical Devices, Indigo is poised to make a significant impact in the healthcare industry with its innovative technology and strong investor support.